Multisystem failure: the story of anti-influenza drugs

@article{Jefferson2014MultisystemFT,
  title={Multisystem failure: the story of anti-influenza drugs},
  author={T. Jefferson and P. Doshi},
  journal={BMJ : British Medical Journal},
  year={2014},
  volume={348}
}
  • T. Jefferson, P. Doshi
  • Published 2014
  • Medicine
  • BMJ : British Medical Journal
  • Last year the Cochrane team, with the help of the BMJ’s open data campaign, finally got access to full clinical study reports on neuraminidase inhibitors. Tom Jefferson and Peter Doshi explain what the new systematic review found and how a series of failures meant that decisions about these drugs were made without the full evidence 
    46 Citations

    Topics from this paper.

    The neuraminidase inhibitors evidence of harms – in context
    • 2
    Authors’ reply to Dunning
    Potential adverse effects of negative publicity surrounding antivirals for influenza
    • J. Dunning
    • Medicine
    • BMJ : British Medical Journal
    • 2014
    • 3
    • PDF
    Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multi-season cohort study.
    • 10
    • PDF
    Ebola in west Africa.
    • 20
    Influenza: the rational use of oseltamivir
    • 22
    Oseltamivir: over 15 years of data retention and systematic stonewalling.
    • Medicine
    • Prescrire international
    • 2016

    References

    SHOWING 1-10 OF 22 REFERENCES
    Neuraminidase inhibitors—the story behind the Cochrane review
    • P. Doshi
    • Medicine
    • BMJ : British Medical Journal
    • 2009
    • 84
    • PDF
    Complications: tracking down the data on oseltamivir
    • D. Cohen
    • Medicine
    • BMJ : British Medical Journal
    • 2009
    • 60
    What does oseltamivir do, and how will we know?
    • 7
    Rethinking credible evidence synthesis
    • 57
    • PDF
    Point-by-point response from Roche to BMJ questions
    • J. Smith
    • Medicine
    • BMJ : British Medical Journal
    • 2009
    • 24
    Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    • 392
    • PDF